Literature DB >> 18345386

Cyclic nitroxides inhibit the toxicity of nitric oxide-derived oxidants: mechanisms and implications.

Ohara Augusto1, Daniel F Trindade, Edlaine Linares, Sandra M Vaz.   

Abstract

The substantial therapeutic potential of tempol (4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy) and related cyclic nitroxides as antioxidants has stimulated innumerous studies of their reactions with reactive oxygen species. In comparison, reactions of nitroxides with nitric oxide-derived oxidants have been less frequently investigated. Nevertheless, this is relevant because tempol has also been shown to protect animals from injuries associated with inflammatory conditions, which are characterized by the increased production of nitric oxide and its derived oxidants. Here, we review recent studies addressing the mechanisms by which cyclic nitroxides attenuate the toxicity of nitric oxide derived oxidants. As an example, we present data showing that tempol protects mice from acetaminophen-induced hepatotoxicity and discuss the possible protection mechanism. In view of the summarized studies, it is proposed that nitroxides attenuate tissue injury under inflammatory conditions mainly because of their ability to react rapidly with nitrogen dioxide and carbonate radical. In the process the nitroxides are oxidized to the corresponding oxammonium cation, which, in turn, can be recycled back to the nitroxides by reacting with upstream species, such as peroxynitrite and hydrogen peroxide, or with cellular reductants. An auxiliary protection mechanism may be down-regulation of inducible nitric oxide synthase expression. The possible therapeutic implications of these mechanisms are addressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18345386     DOI: 10.1590/s0001-37652008000100013

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  13 in total

1.  Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis.

Authors:  Yuji Shirai; Shingo Oda; Sayaka Makino; Koichi Tsuneyama; Tsuyoshi Yokoi
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

2.  Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Colleen E Quigley; Jessica Finch; Kristin M DeMarco; Nicole Nametz; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

3.  Oxidative stress mediates nephropathy in type Ia glycogen storage disease.

Authors:  Wai Han Yiu; Paul A Mead; Hyun Sik Jun; Brian C Mansfield; Janice Y Chou
Journal:  Lab Invest       Date:  2010-03-01       Impact factor: 5.662

4.  Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks.

Authors:  Li-Jeen Mah; Christian Orlowski; Katherine Ververis; Raja S Vasireddy; Assam El-Osta; Tom C Karagiannis
Journal:  Genome Integr       Date:  2011-01-25

5.  SOD mimetic activity and antiproliferative properties of a novel tetra nuclear copper (II) complex.

Authors:  Sagiv Weintraub; Yoni Moskovitz; Ohad Fleker; Ariel R Levy; Aviv Meir; Sharon Ruthstein; Laurent Benisvy; Arie Gruzman
Journal:  J Biol Inorg Chem       Date:  2015-11-07       Impact factor: 3.358

6.  The superoxide dismutase mimetic tempol does not alleviate glucocorticoid-mediated rarefaction of rat skeletal muscle capillaries.

Authors:  Erin R Mandel; Emily C Dunford; Ghoncheh Abdifarkosh; Patrick C Turnbull; Christopher G R Perry; Michael C Riddell; Tara L Haas
Journal:  Physiol Rep       Date:  2017-05

7.  Radio-protective effect and mechanism of 4-Acetamido-2,2,6,6- tetramethylpiperidin-1-oxyl in HUVEC cells.

Authors:  Feng Wang; Peng Gao; Ling Guo; Ping Meng; Yuexing Fan; Yongbin Chen; Yanyun Lin; Guozhen Guo; Guirong Ding; Haibo Wang
Journal:  Environ Health Prev Med       Date:  2017-03-24       Impact factor: 3.674

8.  Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells.

Authors:  Woo Hyun Park
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms.

Authors:  Edlaine Linares; Luciana V Seixas; Janaina N dos Prazeres; Fernando V L Ladd; Aliny A B L Ladd; Antonio A Coppi; Ohara Augusto
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Lipoic acid, but not tempol, preserves vascular compliance and decreases medial calcification in a model of elastocalcinosis.

Authors:  E Bassi; M Liberman; M K Martinatti; L A Bortolotto; F R M Laurindo
Journal:  Braz J Med Biol Res       Date:  2014-01-24       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.